Search
Language: Français

Case Studies: Patients With Platelet Disorders - Series One

 Case Studies: Patients with Platelet Disorders - Series One (9863-08) Learn how to assess information from the problem, clinical data and laboratory findings to resolve disorders such as neonatal alloimmune thrombocytopenia, gray platelet syndrome, Glanzmann's thrombasthenia, post-infectious thrombocytopenia, and the use and abuse of bleeding times.

Code 9863-08
Level Basic

Member Price

$0

Non-Member Price

$110

 

Additional Details

PEP hours: 16
CPS/ART credits: 0
Level: Basic
Course Type: Express
 
Start Date: Upon registration
Completion: Up to 52 weeks
Delivery: PDF via email
 
Prerequisites: None
Textbook: N/A
Equipment: Computer with Internet is required
 
Learning Outcomes:
  • Describe the mechanisms of neonatal alloimmune thrombocytopenia.
  • Detail the difference between alloimmune thrombocytopenic purpura and HDNB.
  • Tabulate the characteristics of common platelet antigens
  • Discuss the value of testing for platelet antigens.
  • Outline the features of platelets with defects of platelet granules.
  • Describe the morphological appearance of platelets with Gray Platelet Syndrome.
  • Discuss the diagnostic and treatment options for patients with Gray Platelet Syndrome.
  • Describe the functional defects seen in patients with deficiencies of specific platelet glycoproteins.
  • Briefly review the genetics of patients with platelet functional disorders.
  • Explain the theory of platelet aggregation tests.
  • Tabulate the clinical and laboratory results seen in patients with hereditary platelet functional disorders.
  • Discuss the logic and value of using the terms “idiopathic” and “immune” thrombocytopenia.
  • Outline the laboratory features of childhood thrombocytopenia.
  • Discuss in detail the pros and cons of the bleeding time test.
  • List the many causes for an abnormal bleeding time test.
  • Tabulate some of the many drugs that interfere with platelet function tests.
  • Describe the procedure for performing a clinically significant bleeding time test.
  • Prepare sensitivity, specificity, positive predictive value and negative predictive value results from laboratory data provided.
Author/Instructor:  John Chapman, FCSMLS, FIMLS, CLSp(H)
Version Date: November 2008